Open Access

Poster Session 6 - Long term prognosis in coronary artery disease

Event: ESC CONGRESS 2019
Topic: European Society of Cardiology
Session type: Poster Session
Date: 3 September 2019

Session

10 presentations in this session

Vascular endothelial growth factor-D and mortality in suspected or known coronary heart disease patients with chronic kidney disease: a subanalysis of the ANOX study

Speaker: Doctor H. Wada (Kyoto, JP)
Thumbnail

Association of atherogenic dyslipidemia with cardiovascular outcomes in patients with pre-diabetes and coronary artery disease

Speaker: Doctor Y. Gao (Beijing, CN)
Thumbnail

Extremely elevated lipoprotein (a) as an independent risk factor for coronary heart disease in large patient cohort

Speaker: Mr M. Poudel (Bielefeld, DE)
Thumbnail

Vascular endothelial growth factor-D and mortality in suspected or known coronary heart disease patients with diabetes: a subanalysis of the ANOX study

Speaker: Miss M. Wada (Kyoto, JP)
Thumbnail

The low expression of circulating microRNA-19a represents an additional mortality risk in stable patients with vascular disease.

Speaker: Professor O. Mayer (Plzen, CZ)
Thumbnail

A systematic follow-up strategy after percutaneous coronary intervention based on patient risk profile: the prospective POST-PCI registry

Speaker: Doctor M. Ferlini (Pavia, IT)
Thumbnail

Predictive value of objective nutritional scores for contrast-induced acute kidney injury in elderly patients undergoing percutaneous coronary intervention

Speaker: Doctor K. Lin (Fuzhou, CN)
Thumbnail

A study on the impact of community intervention on the time from symptom onset to first medical contact in patients of acute coronary syndrome

Speaker: Doctor M. Wang (Hangzhou, CN)
Thumbnail

Causes and predictors of short, intermediate and long-term mortality in patients after PCI

Speaker: Doctor M. Zeitouni (Paris, FR)
Thumbnail

Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: a 1-year analysis of the REDUCE trial

Speaker: Doctor M. Verdoia (Biella, IT)
Thumbnail

10 speakers from this session

Doctor Hiromichi Wada

National Hospital Organization Kyoto Medical Center, Kyoto (Japan)
0 follower

Doctor Ying Gao

Fuwai Hospital, CAMS and PUMC, Beijing (China)
0 follower

Mr Madan Raj Poudel

University Clinic OWL, Bielefeld (Germany)
1 follower

Miss Miyaka Wada

Kyoto Medical Centre, Kyoto (Japan)
0 follower

Professor Otto Mayer

2nd Dept. of Internal Medicine, University Hospital, Plzen (Czechia)
0 follower

Doctor Marco Ferlini

Foundation IRCCS Polyclinic San Matteo - University of Pavia, Pavia (Italy)
0 follower

Doctor Kaiyang Lin

Fujian Provincial Hospital, Fuzhou (China)
0 follower

Doctor Mingwei Wang

Affiliated Hospital of Hangzhou Normal University, Hangzhou (China)
0 follower

Doctor Michel Zeitouni

Hospital Pitie-Salpetriere, Paris (France)
0 follower

Doctor Monica Verdoia

ASL Biella Hospital of the Sick University of Eastern Piedmont, Biella (Italy)
0 follower

This platform is supported by

logo Novo Nordisk